SOHM (OTC:SHMN) Stock, Quote.Headers.trade-ideas

SOHM Inc is a pharmaceutical, cosmeceutical, nutraceutical and biotech manufacturer that produces and markets generic drugs and products for various treatment categories. Its products include OTC and RX: Generic CDMO Services, and ABBIE Systems. The organization markets and sells its generic drugs globally but focuses on emerging markets in Africa, Latin America, Southeast Asia, and the European Union. It recognizes revenue upon the accrual of interest earned on the tax lien certificates owned, as well as liquidating revenue from properties sold that the Company received through the settlement of unredeemed tax lien certificates.

SOHM Inc

News

Press Releases

SOHM, Inc. Shares Groundbreaking Findings in ABBIE Technology

SOHM, Inc. Launches New AI Team to Advance ABBIE System and Genome Editing Innovations

SOHM, Inc. Shares an Exciting Expansion and Upcoming Presentation on ABBIE

SOHM, Inc.  Announces Patent Allowance/Approval in South Korea

SOHM, Inc. Agrees to Licensing for Investigational and Pre-Clinical Studies for Groundbreaking ABBIE Genome Editing Technology for CAR-T Cell Cancer Therapies

SOHM Inc. Awarded European Patent for Innovative ABBIE Genome Editing Technology

Management

Dr. Leonardo Mirandola Joins SOHM, Inc. as an Advisory Board to Advance CAR-T Cell Projects Toward Clinical Trials and Commercialization

SOHM, Inc., Unveils Genetically Engineered Ovarian Cancer Cell Line Using ABBIE(TM) Platform to Accelerate GYS1 Drug Discovery

SOHM Inc. Welcomes Dr. Lucia Piccotti to Offer Expert Guidance on Cosmeceutical and Personal Health Product Research and Development

SOHM Inc. Welcomes Dr. Larissa Karnaoukhova as New Vice President of Operations

SHMN

SOHM

Comments

SOHM

SOHM (OTC:SHMN) Stock, Quote.Headers.trade-ideas

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell